학술논문
Survival advantage for immunochemotherapy (R-MCP) over chemotherapy (MCP) alone in advanced follicular lymphoma after a median follow up of 5 years - updated results of the OSHO#39 study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
0378584X